HOPPS Proposed Rule Would Grow Site-Neutral Imaging Payments
ACR® has prepared a preliminary summary of the 2027 HOPPS proposed rule released by CMS July 2. CMS proposes to increase outpatient hospital payment rates by 2.4%.
Read moreThe American College of Radiology® (ACR®) issued a statement expressing strong support for the Medicare Patient Access and Practice Stabilization Act of 2024 introduced Oct. 29, in the U.S. House of Representatives. The bill was introduced by Rep. Greg Murphy, MD, (R-NC), joined by Reps. Jimmy Panetta (D-CA), Mariannette Miller-Meeks, MD, (R-IA), Ami Bera, MD, (D-CA), Bucshon, MD, (R-IN), Raul Ruiz, MD, (D-CA), John Joyce, MD, (R-PA), and Kim Schrier, MD, (D-WA). The legislation, strongly supported by the House of Medicine, would eliminate the 2025 Medicare Physician Fee Schedule (MPFS) conversion factor (CF) reduction scheduled to hit Jan. 1, and add an additional 1.8% to the CF to partially address inflationary costs.
ACR urges all College members to contact their representative and ask them to cosponsor and work to advance the Medicare Patient Access and Practice Stabilization Act of 2024. Passage of this bill is urgent; Congress must act soon to ensure stability for both physicians and Medicare beneficiaries in 2025.
For more information or if you have questions, contact Rebecca Spangler, Senior Government Relations Director.
HOPPS Proposed Rule Would Grow Site-Neutral Imaging Payments
ACR® has prepared a preliminary summary of the 2027 HOPPS proposed rule released by CMS July 2. CMS proposes to increase outpatient hospital payment rates by 2.4%.
Read moreACR Weighs in on NRC Standard General License Proposal
ACR supports easing NRC licensing burdens but urges limits on new SGL use, ensuring existing training standards and clarity within broader regulatory reforms.
Read moreDr. Pisano Highlights ACR AI Leadership and Builds International Connections
Etta Pisano urged global collaboration on safe, effective medical AI and highlighted ACR programs advancing AI standards and clinical trial innovation.
Read more